Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Mirella NardoBulent YilmazBlessie Elizabeth NelsonHarrys A TorresLan Sun WangBruno Palma GranwehrJuhee SongHanna R F Dalla PriaVan A TrinhIsabella C Glitza OlivaSapna P PatelNizar M TannirAhmed Omar KasebMehmet AltanSunyoung S LeeEthan MillerHao ZhangBettzy A StephenAung Naing

Published in: The oncologist (2023)

ICIs may be a therapeutic option with an acceptable safety profile in patients with cancer and advanced liver disease.

Keyphrases

papillary thyroid
sars cov
squamous cell
molecular dynamics
squamous cell carcinoma